Safety and Efficacy of Nicardipine for the Control of Blood Pressure After SAH

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00490464

Enrollment

163

Registered

2007-06-22

Start date

2004-06-30

Completion date

2007-02-28

Last updated

2007-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intracerebral Hemorrhage, Subarachnoid Hemorrhage

Keywords

Patients with SAH or ICH

Brief summary

The purpose of this research is to explore ways to improve and simplify control of blood pressure in patients with SAH or ICH. This research will be done by comparing tow different medications that are routinely used to help control blood pressure. None of the medications used in this study nor any procedures performed are experimental.

Interventions

DRUGNicardipine and Nipride

Study design

Observational model

DEFINED_POPULATION

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 70 Years

Healthy volunteers

Inclusion criteria

* 18-70 years old (inclusive) * Admission to NSICU with a diagnosis of SAH or ICH

Exclusion criteria

* Patients who are admitted \>48 hours after SAH or ICH * Readmission or second SAH * Readmission or second ICH * Large (immediately life threatening) associated intraparenchymal or intraventricular hemorrhage * Women who are pregnant

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026